1. Home
  2. PESI vs TLSI Comparison

PESI vs TLSI Comparison

Compare PESI & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$10.98

Market Cap

208.1M

Sector

Industrials

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$3.97

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
TLSI
Founded
1990
2010
Country
United States
United States
Employees
N/A
102
Industry
Environmental Services
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
270.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PESI
TLSI
Price
$10.98
$3.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
170.7K
312.2K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
N/A
Revenue This Year
$34.62
$35.45
Revenue Next Year
$77.02
$37.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.14
$2.20
52 Week High
$16.50
$7.95

Technical Indicators

Market Signals
Indicator
PESI
TLSI
Relative Strength Index (RSI) 56.29 55.86
Support Level $9.58 $3.70
Resistance Level $14.80 $4.30
Average True Range (ATR) 0.65 0.35
MACD 0.22 0.11
Stochastic Oscillator 80.44 62.62

Price Performance

Historical Comparison
PESI
TLSI

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: